Molecular%20Mechanisms%20of%20Pharmacological%20Action
Showing 1 - 25 of >10,000
Molecular Mechanisms of Pharmacological Action, Depression, Depressive Disorder Trial in Oxford (Prucalopride, Placebo)
Completed
- Molecular Mechanisms of Pharmacological Action
- +6 more
- Prucalopride
- Placebo
-
Oxford, United KingdomUniversity of Oxford
Nov 14, 2022
Tobacco Dependence, Smoking Cessation, Tobacco Smoking Trial in Toronto (Varenicline, Active tDCS, Sham tDCS)
Completed
- Tobacco Dependence
- +6 more
- Varenicline
- +2 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Mar 14, 2022
Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)
Recruiting
- Prader-Willi Syndrome
- +20 more
- Guanfacine Extended Release
- Placebo
-
Brooklyn, New YorkMaimonides Medical Center
Dec 20, 2022
Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)
Not yet recruiting
- Breast Cancer
- +12 more
-
Opole, Opolskie, Poland
- +3 more
Jul 15, 2022
Delirium, Cognitive Dysfunction, Cognition Disorder Trial in Toronto (Dexmedetomidine Hydrochloride Group)
Recruiting
- Delirium
- +16 more
- Dexmedetomidine Hydrochloride Group
-
Toronto, Ontario, CanadaSunnybrook Health Sciences Centre
Mar 14, 2022
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)
Recruiting
- Non-Small Cell Lung Cancer
- +14 more
-
Glendale, California
- +12 more
Feb 2, 2023
Muscle Recovery Trial in Exeter (500 ml base solution, 500 ml containing 30 ml tart cherry concentrate diluted with water and
Recruiting
- Muscle Recovery
- 500 ml base solution
- +2 more
-
Exeter, UK, United KingdomUniversity of Exeter Sport and Health Sciences Department
Nov 10, 2022
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010; paliperidone palmitate, INVEGA SUSTENNA)
Active, not recruiting
- Schizophrenia
- +11 more
- LY03010; paliperidone palmitate
- INVEGA SUSTENNA
-
Garden Grove, California
- +8 more
Nov 19, 2021
Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156
Recruiting
- Schizophrenia
- +11 more
- LY03010 156 mg treatment group, deltoid
- +3 more
-
Little Rock, Arkansas
- +8 more
Apr 11, 2022
Primary Sclerosing Cholangitis (PSC) Trial in Warsaw (S-Adenosyl-L-methionine (SAMe), Placebo)
Recruiting
- Primary Sclerosing Cholangitis (PSC)
- S-Adenosyl-L-methionine (SAMe)
- Placebo
-
Warsaw, PolandDepartment of Hepatology, Transplantology and Internal Medicine,
Sep 4, 2023
Hepatocellular Carcinoma, Liver Tumors, Digestive System Tumors Trial in Chengdu (TACE combined with sorafenib and PD-1 mAb)
Recruiting
- Hepatocellular Carcinoma
- +7 more
- TACE combined with sorafenib and PD-1 mAb
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital and Research Institute
Sep 14, 2020
NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)
Recruiting
- Non-Small Cell Lung Cancer
- +13 more
- furmonertinib 240 mg
- +2 more
-
Yuma, Arizona
- +37 more
Dec 14, 2022
Ovarian Tumors, Fallopian Tube Tumors, Endocrine Gland Tumors Trial in Nanjing (Niraparib, Bevacizumab)
Unknown status
- Ovarian Neoplasms
- +23 more
-
Nanjing, Jiangsu, ChinaJiangSu Cancer Hospital
Nov 8, 2020
Molecular Mechanisms of Pharmacological Action, Depression, Depressive Disorder Trial in Oxford (Citalopram, Placebo oral
Unknown status
- Molecular Mechanisms of Pharmacological Action
- +5 more
- Citalopram
- Placebo oral tablet
-
Oxford, United KingdomUniversity of Oxford
Nov 18, 2019
Delirium, Postoperative Complications, Pathologic Processes Trial in Wenzhou (Dexmedetomidine)
Unknown status
- Delirium
- +9 more
-
Wenzhou, Zhejiang, ChinaThe second Affiliated Hospital and Yuying Children's Hospital of
Sep 23, 2019
Cardiomyopathy, Familial Trial in Montpellier (Electrocardiogram, physical examination, echocardiography)
Completed
- Cardiomyopathy, Familial
- Electrocardiogram
- +3 more
-
Montpellier, Occitanie, FranceCHU Arnaud de Villeneuve
Dec 13, 2022
Dissecting Cellular and Molecular Atlas of Rheumatoid Arthritis
Recruiting
- Rheumatoid Arthritis
- Tapering and/or discontinuation of treatment based on AI-guidance
- +3 more
-
Rome, Italy
- +3 more
Jul 20, 2023
Depression, Unipolar Trial (Intravenous Ketamine)
Not yet recruiting
- Depression, Unipolar
- Intravenous Ketamine
- (no location specified)
Aug 6, 2023
Action of Interferon in Treatment of Myeloproliferative
Recruiting
- Myeloproliferative Neoplasm
-
Villejuif, Ile De France, FranceInserm U1287
Apr 28, 2023
Stomach Tumors, Gastrointestinal Tumors, Stomach Diseases Trial (Apatinib, Capecitabine)
Not yet recruiting
- Stomach Neoplasms
- +7 more
- (no location specified)
Mar 23, 2019
Molecular Mechanisms of Pharmacological Action, Depression, Depressive Disorder Trial in Oxford (Prucalopride, Placebo)
Completed
- Molecular Mechanisms of Pharmacological Action
- +6 more
- Prucalopride
- Placebo
-
Oxford, United KingdomUniversity of Oxford
Mar 1, 2019
IBD Trial in Tanta (Mesalamine, Fenofibrate 160mg)
Recruiting
- Inflammatory Bowel Diseases
- Mesalamine
- Fenofibrate 160mg
-
Tanta, EgyptTanta Unuversity
Mar 6, 2023
Aging, Insulin Resistance Trial in Madison (Everolimus 0.5 MG once per day, Everolimus 5 MG once per week, Placebo once per day)
Recruiting
- Aging
- Insulin Resistance
- Everolimus 0.5 MG once per day
- +3 more
-
Madison, WisconsinUniversity of Wisconsin-Madison
Apr 19, 2023